Ginkgo Bioworks Holdings (DNA) Accounts Payables: 2020-2025
Historic Accounts Payables for Ginkgo Bioworks Holdings (DNA) over the last 5 years, with Sep 2025 value amounting to $10.7 million.
- Ginkgo Bioworks Holdings' Accounts Payables fell 31.82% to $10.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.7 million, marking a year-over-year decrease of 31.82%. This contributed to the annual value of $14.2 million for FY2024, which is 51.98% up from last year.
- Per Ginkgo Bioworks Holdings' latest filing, its Accounts Payables stood at $10.7 million for Q3 2025, which was down 4.45% from $11.2 million recorded in Q2 2025.
- In the past 5 years, Ginkgo Bioworks Holdings' Accounts Payables ranged from a high of $35.3 million in Q1 2022 and a low of $1.4 million during Q1 2021.
- Moreover, its 3-year median value for Accounts Payables was $13.6 million (2023), whereas its average is $15.3 million.
- In the last 5 years, Ginkgo Bioworks Holdings' Accounts Payables spiked by 2,379.71% in 2022 and then tumbled by 58.26% in 2025.
- Quarterly analysis of 5 years shows Ginkgo Bioworks Holdings' Accounts Payables stood at $8.2 million in 2021, then climbed by 27.62% to $10.5 million in 2022, then fell by 10.79% to $9.3 million in 2023, then surged by 51.98% to $14.2 million in 2024, then slumped by 31.82% to $10.7 million in 2025.
- Its last three reported values are $10.7 million in Q3 2025, $11.2 million for Q2 2025, and $11.3 million during Q1 2025.